Erythroblastosis Fetalis(Archived)
- PMID: 30020664
- Bookshelf ID: NBK513292
Erythroblastosis Fetalis(Archived)
Excerpt
Hemolytic disease of the fetus and newborn (HDFN), also known as alloimmune HDFN or erythroblastosis fetalis, is caused by the destruction of red blood cells (RBCs) of the neonate or fetus by maternal immunoglobulin G (IgG) antibodies. The formation of maternal antibodies in response to a fetal antigen is called isoimmunization. These antibodies form when fetal erythrocytes with specific RBC antigens not expressed in the mother cross the placenta and gain access to maternal blood. This antibody response may be sufficient to destroy fetal red cells, leading to hemolysis, the release of bilirubin, and anemia. The severity of the illness in the fetus depends on various factors, including the amount and strength of antibodies produced by the mother, the fetus's gestational age, and the fetus's ability to replenish the destroyed RBCs and clear bilirubin.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med. 2008 Aug;13(4):207-14. - PubMed
-
- Gandhi MJ, Strong DM, Whitaker BI, Petrisli E. A brief overview of clinical significance of blood group antibodies. Immunohematology. 2018 Jan;33(1):4-6. - PubMed
-
- Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017 Aug;130(2):481-483. - PubMed
-
- Hartwell EA. Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists. Am J Clin Pathol. 1998 Sep;110(3):281-92. - PubMed
Publication types
LinkOut - more resources
Full Text Sources